Abstract
ObjectiveAlthough Pap smear (PS) is considered the best standard in detecting cervical cancer, adherence to timely and regular PS is often lower than global standards in developing countries. Thus, the present study aimed to identify barriers and facilitators of adherence to cervical cancer screening in Mashhad, Iran.DesignA qualitative content analysis was done from July to December 2022 using semistructured in-depth interviews.SettingThe study was conducted in health centres in Mashhad, Iran.ParticipantsA sample of 36 married women aged 18–70 years was selected using a purposive sampling, with maximum diversity.ResultsThe mean age of participants was 42.8±7.6 years. Among all, 66.7% had the PS test at least once; only 8.3% regularly had the test. The qualitative content analysis led to the extraction of four major themes: (1) individual challenges, (2) environmental limitations, (3) individual motivators, and (4) supportive and efficient environments. The most significant barriers were psychological stress, unhealthy attitudes, insufficient information, cultural issues and insufficient healthcare services. Facilitators included an active and efficient healthcare system, advice and support of important others, and positive emotions and individual beliefs.ConclusionsParticipants' perceptions showed that the main factors influencing the PS testing were supportive environments, individual motivators, individual challenges and environmental limitations. To encourage women to take the PS and reduce barriers, it may be necessary to revise current health system policies, promote individual and public awareness, reduce psychological stress and correct negative beliefs and attitudes.
Reference43 articles.
1. TAaC L . Cervical cancer screening the International agency for research on cancer (IARC). 2022: 467.
2. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
3. The needs of women referring to health care centers for doing PAP smear tests;Fallahi;The Iranian Journal of Obstetrics, Gynecology and Infertility,2016
4. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
5. WHO . Who. INT/teams/Noncommunicable diseases/surveillance/data/Cervical-cancer-profiles. 2022. Available: https://www.who.int/teams/noncommunicable-diseases/surveillance/data/cervical-cancer-profiles
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献